CardioClin™ Clinical Evidence & Research

HeartForce™ technology is backed by robust clinical science. From 2019 to 2023, we conducted a multicenter study to develop and validate our Electro-mechanical CAD Response Score (EMCR Score™) for non-invasive coronary artery disease screening.

Doctors discussing CardioClin EMCR score patient data report

Clinically Validated.
AI-Powered Accuracy.

Electro-mechanical CAD Response Score (EMCR Score™) multicenter clinical study¹,²

Study Design & Population

The study enrolled 2,110 individuals, including:

  • Patients with significant CAD (defined as ≥50% stenosis)
  • Healthy age-matched control group
  • Individuals with mild to moderate occlusions

This diverse cohort ensured a balanced dataset, representative of real-world patient profiles across the CAD risk spectrum.

Electro-mechanical CAD Risk Score Clinical Evidence

Validation Methods

Gold-standard diagnostic tests — Coronary CT Angiography (CCTA) and Invasive Coronary Angiography (ICA) — confirmed the findings.

Rule-out performance

Our clinical study shows that the Electro-mechanical CAD Response Score™ performed a far greater rule-out capability than a Calcium Score and Stress ECG.

Across our data set the EMCR Score™ had a:

94%
Sensitivity
95%
Negative Predictive Value
0.098
Negative Likelihood Ratio

Percentage of CAD Positive Patients in Each Category

CAD prevalence by EMCR risk category
Very Low Risk
Low Risk
Intermediate Risk
High Risk
Very High Risk
0%
50%
100%

Related Scientific Perspectives

Beyond disease-specific CAD research, international cardiovascular societies continue to emphasize earlier identification of individuals at cardiovascular risk and preventive care before structural heart disease develops. This broader direction is reflected in the Second Universal Definition of Heart Failure (AHA, ACC, ESC, WHF, 2026).

Published Research

HeartForce’s team is composed of industry leaders in life sciences, medicine, biomedical engineering, and technology. Our research and clinical studies continually advance the fields of medical technology and seismocardiography.

Discover our publications below to learn more:

2026

Download article

  • Electro-Mechanical Risk Score for Non-Invasive Stratification of Obstructive Coronary Artery DiseaseTo be presented by Parastoo Dehkordi — Canadian Cardiovascular Congress 2026 (CCC2026), Thursday, October 15, 2026, 1:00–1:30 PM (Eastern)
  • AI-driven electromechanical model for non-invasive CAD risk assessment across symptom profilesPresenter: Richard Kobza — European Society of Cardiology (ESC) Congress 2026, Munich

2025

Download article

2024

2023

Download article

2022

2021

Download article

2020

2019

Download article

Download article

HeartForce™ welcomes collaborative research partnerships to further expand the clinical and scientific understanding of SCG and CAD risk stratification.

For further information, please contact:

Dr. Parastoo Dehkordi

Email: info@heartforce.com

  1. Dehkordi P, Tavakolian K, Xiao ZG, Khosrow-Khavar F. Introducing the electromechanical risk factor score derived from seismocardiography for estimating the likelihood of coronary artery disease. In: 2023 Computing in Cardiology (CinC); Vol. 50, pp. 1–4. Available from: https://doi.org/10.22489/CinC.2023.371
  2. Dehkordi P, Tavakolian K, Xiao ZG, Yuldashov A, Khosrow-Khavar F. Assessing coronary artery disease risk using seismocardiography in patients with chest pain. In: 2025 47th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC); 2025 July 14–18; Copenhagen, Denmark. IEEE; 2025. Available from: https://doi.org/10.1109/EMBC58623.2025.11254413

You are leaving the US website

You are leaving the US version of the HeartForce website and entering our global website.

Product availability, regulatory status, risk categorisation, and performance claims may differ between regions and may not apply to the United States.

CardioClin™ is not cleared or approved by the U.S. Food and Drug Administration (FDA).

Please return to the US website for information applicable to the United States.